Yiheng Capital Management, L.P. Top Holdings and 13F Report (2024) About Yiheng Capital Management, L.P.Investment ActivityYiheng Capital Management, L.P. has $1.95 billion in total holdings as of June 30, 2024.Yiheng Capital Management, L.P. owns shares of 17 different stocks, but just 2 companies or ETFs make up 80% of its holdings.Approximately 29.53% of the portfolio was purchased this quarter.About 15.29% of the portfolio was sold this quarter.This quarter, Yiheng Capital Management, L.P. has purchased 24 new stocks and bought additional shares in 4 stocks.Yiheng Capital Management, L.P. sold shares of 7 stocks and completely divested from 7 stocks this quarter.Largest Holdings JD.com $818,015,360Bilibili $796,584,048Noah $82,854,172H World Group $59,667,982New Oriental Education & Technology Group $39,308,934 Largest Purchases this Quarter JD.com 14,177,595 shares (about $567.10M)ACM Research 220,200 shares (about $4.47M)TAL Education Group 251,900 shares (about $2.98M)ATRenew 196,965 shares (about $547.56K) Largest Sales this Quarter Bilibili 1,915,175 shares (about $44.78M)Roblox 720,361 shares (about $31.88M)Akero Therapeutics 675,410 shares (about $19.38M)Denali Therapeutics 550,586 shares (about $16.04M)New Oriental Education & Technology Group 139,315 shares (about $10.57M) Sector Allocation Over TimeMap of 500 Largest Holdings ofYiheng Capital Management, L.P. Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorJDJD.com$818,015,360$567,103,800 ▲226.0%20,450,38442.0%Retail/WholesaleBILIBilibili$796,584,048$44,776,791 ▼-5.3%34,071,17440.9%Computer and TechnologyNOAHNoah$82,854,1720.0%6,719,7224.3%FinanceHTHTH World Group$59,667,9820.0%1,603,9783.1%Consumer DiscretionaryEDUNew Oriental Education & Technology Group$39,308,934$10,565,650 ▼-21.2%518,3142.0%Consumer DiscretionaryTALTAL Education Group$25,901,397$2,982,496 ▲13.0%2,187,6181.3%Consumer DiscretionaryRBLXRoblox$22,146,952$31,883,178 ▼-59.0%500,3831.1%Consumer DiscretionaryAKROAkero Therapeutics$21,769,083$19,377,513 ▼-47.1%758,7691.1%MedicalVRDNViridian Therapeutics$19,289,520$2,280,437 ▼-10.6%847,8911.0%MedicalBEAMBeam Therapeutics$18,712,120$2,002,630 ▼-9.7%763,7601.0%MedicalDNLIDenali Therapeutics$17,480,855$16,038,570 ▼-47.8%600,0980.9%MedicalACMRACM Research$13,525,971$4,470,060 ▲49.4%666,3040.7%Computer and TechnologyIVAInventiva$4,932,7870.0%2,644,9260.3%MedicalREREATRenew$4,234,657$547,563 ▲14.9%1,523,2580.2%Business ServicesDBV TECHNOLOGIES S A$2,207,5030.0%3,153,5760.1%SPONSORED ADRGBIOGeneration Bio$473,0790.0%191,5300.0%MedicalTOURTuniu$446,5010.0%314,4370.0%Computer and TechnologySMCISuper Micro Computer$0$61,451,250 ▼-100.0%00.0%Computer and TechnologyMBLYMobileye Global$0$44,941,617 ▼-100.0%00.0%Auto/Tires/TrucksTDGTransDigm Group$0$33,244,690 ▼-100.0%00.0%AerospaceGPIGroup 1 Automotive$0$26,933,568 ▼-100.0%00.0%Retail/WholesaleLADLithia Motors$0$3,281,850 ▼-100.0%00.0%Retail/WholesaleCOMMCommScope$0$898,979 ▼-100.0%00.0%Computer and TechnologyJIANZHI ED TECHNOLOGY GROUP$0$14,907 ▼-100.0%00.0%SPONSORED ADRShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
